latest newsRead more...
12
Dec 2018Oxforb BioTherapeutics expands its strategic collaboration with WuXi Biologics
WuXi Biologics HK a leading global open source biological technology platform company offering integrated solutions for discovery development and biological and Oxford manufacturing BioTherapeutics Ltd OBT a clinical stage oncology company with a portfolio of immunooncological treatments and joint antibody drugs today announced the expansion…
12
Dec 2018Vect-Horus Announces Agreement With Johnson & Johnson Innovation
VectHorus announced today the signing of a research collaboration agreement with Janssen Pharmaceuticals Inc one of the Janssen Pharmaceutical Companies of Johnson Johnson The goal of this collaboration is to use VectHorus proprietary technology to transport various Janssen monoclonal antibodies to the brain for the…
11
Dec 2018GeneCentric Therapeutics Enters Bladder Cancer Research Collaboration with University of North Carolina
GeneCentric Therapeutics Inc today announced that it has entered into a research collaboration with the University of North Carolina at Chapel Hill UNC to assess patient response to immunotherapeutic drugs such as PD and PDL inhibitors based on bladder cancer subtypes The collaboration will augment…
11
Dec 2018HitGen and Mitsubishi Tanabe Pharma Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration
HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Mitsubishi Tanabe Pharma Corporation President and CEO Masayuki Mitsuka Headquarters Osaka MTPC to identify novel small molecule leads for targets of interest According to the agreement HitGen will apply its…
10
Dec 2018WuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel Bispecific Antibody Immunotherapeutics
WuXi Biologics a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing announced today a strategic collaboration with Brii Biosciences Brii Bio an innovative biotechnology company operates in China and the US focusing on accelerating innovation and optimizing…
press releasesRead more...
12
Dec 2018WuXi Biologics Achieves Breakthrough Titer of 51g/L in Cell Culture Productivity
WuXi Biologics HK a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing today announced that it has achieved a breakthrough in cell…
12
Dec 2018Amgen And Magellan Rx Management Collaborate To Improve Patient Care For Chronic, Difficult-To-Treat Conditions
Amgen today announced a novel multiyear collaboration with Magellan Rx Management the pharmacy benefit management division of Magellan Health that will leverage each companys capabilities and resources to identify clinical…
11
Dec 2018Bragar Eagel & Squire, P.C. is Investigating Teladoc Health, Inc. (TDOC) on Behalf of Stockholders and Encourages TDOC Investors to Contact the Firm
NEW YORK Dec GLOBE NEWSWIRE Bragar Eagel Squire PC is investigating potential claims against Teladoc Health Inc NYSE TDOC Our investigation concerns whether Teladoc has violated the federal securities laws…
11
Dec 2018Merck and genOway enter into a strategic alliance to develop rodent models using CRISPR / Cas9
Merck a leading science and technology company and pioneer in genome editing today announced a strategic alliance with French biotechnology company genOway in the market for CRISPR Casbased rodent models…
11
Dec 2018Tissue Regeneration Therapeutics and RoosterBio Inc. Form Strategic Alliance to Commercialize Umbilical Cord Tissue Cell Technology
Today Tissue Regeneration Therapeutics Inc TRT and RoosterBio Inc RBI announce an important strategic alliance to advance their shared goal of accelerating the development of the Regenerative Medicine and Cellular…
EventsRead more...
09-13
Dec 2018Antibody Engineering & Therapeutics
KNect365
Manchester Grand Hyatt San Diego
12-13
Dec 20183rd New Product Planning Summit
ExL Events, Inc.
Hilton Boston Back Bay
13-14
Dec 201813th International Conference on Allergy and Clinical Immunology
ME Conferences
Radisson Blu Hotel
13-15
Dec 2018Advances in Inflammatory Bowel Diseases
Imedex
Walt Disney World Dolphin Hotel
TOP ARTICLES
-
1
Identification of MicroRNAs and Their Targets in Cancer
Although our cells are well equipped with regulatory checkpoints transformation of normal cells to malignant cancerous cells often occurs as a genetic disease W..
-
2
Smart Nano-Enabled Drug Carrier in Combating Tumor Development and Progress
Introduction The worldwide report of mortality due to lethal disease cancer is common and progressive nowadays Although nanomedicine advances in tumor biolog..
-
3
Are you Ready for EU FMD?
With the deadline looming for enactment of EU FMD and US DSCSA Vikash Pushpraj Senior Vice President rfxcel explains how achieving compliance is about much more..
-
4
Life-style, Environment, and Lack of Prediabetes Diagnosis Fueling Diabetic Epidemic
Introduction For the past ten years ample evidence exists to suggest that what we eat and how we live determines how our body and genes behave A rapid rise i..
-
5
Cancer Stem Cell (CSC) Inhibitors
Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease H..
-
6
Enhancement of the Aqueous Solubility and Permeability of Poorly Water- Soluble Drugs
Introduction Combinatorial chemistry High Throughput Screening technique HTS and other computeraided methods have proved their usefulness for drug design and..
Knowledge Bank
-
Interviews
Merck
Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot..
-
Articles
SPC and Evaluation of Analyst Performance
Introduction Statistical Process Control SPC has become valuable tools in different areas in human life notably healthcare industry including the pharmaceutical field In general SPC provides a visually quantitative measure for specifically monitored inspection properties Accordingly it assesses the degree of control on the investigated characteristic efficiency staebility quality any improvements required and the…
-
Research Insights
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine
Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to investigate the efficacy and safety of afatinib an irreversible ErbB family inhibitor alone and in combination with vinorelbine…
-
Case Studies
Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study
Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime WGS with routine MTBC diagnostic workflows Methods We compared…
-
Techno Trends
Alnylam’s ONPATTRO to Treat Patients with Hereditary ATTR Amyloidosis in Adults
Alnylams ONPATTRO patisiran lipid complex injection is a firstofitskind RNA interference RNAi therapeutic used to treat the polyneuropathy of hereditary transthyretinmediated hATTR Amyloidosis in adults RNAi is a completely new approach to the treatment of these diseases targeting the faulty protein that is causing the disease rather than treating the symptoms RNAi therapeutic is an entirely new class of medicines…
-
White Papers
Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper
Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward ascending regions such as India and China to…
-
Industry Reports
Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review
Sanochemia Pharmazeutika AG Sanochemia is a specialty pharmaceutical company that develops and manufactures of innovative drugs and diagnostics in selected indication areas such as neurodegeneration pain and cancer as well as diagnostic products based on contrast media The companys product portfolio includes radiological products including an array of xray imaging…
Advisory Board
Editorial Section
-
Strategy
Statin Drug Interactions and Related Adverse Reactions
Statins are generally well tolerated with a low frequency of adverse events but since statins are prescribed on a longterm basis many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment and potentially interacting…
-
Research development
Stem Cell and Gene Delivery
These days gene and stem cell therapies have the potential to make the substantial impact on the treatment of several diseases However there are pros and cons of each strategy but the optimal selection of gene delivery vector or stem…
-
Clinical Trials
Managing Clinical Trial Agreements
Clinical Trial Agreements set out how a clinical trial will be run at the site and are an essential GCP document There are a number of key factors that determine whether a Clinical Trial Agreement is successful in achieving that…
-
Manufacturing
Drug Concentration Assurance of Continuous Tablet Manufacturing
In the pharmaceutical industry Real Time Release RTR can be facilitated by the development of a highly efficient control system The drug concentration in final tablet is one of the most critical quality attributes that…
-
Information Technology
R&D DATA HUB
Faster decision making and better trial oversight at all levels requires truly next generation data integration and analytics Source and format agnostic data aggregation aided by modern data lake architecture and advanced analytics deliver interactive…
